Improving clinical trials with AI. Michelle Gallaher, Opyl.
Opyl CEO, Michelle Gallaher, discussed clinical trials, Opin and Trial Key on the Talking HealthTech podcast.
Michelle Gallaher, CEO of Opyl, discussed Opin, communication with patients in clinical trials, COVID’s impact on clinical trials, and Trial Key on episode 292 of the Talking HealthTech podcast.
Listen to the episode on Talking HealthTech: https://www.talkinghealthtech.com/podcast/292-improving-clinical-trials-with-ai-michelle-gallaher-opyl